In this week’s edition of InnovationRx, we look at BillionToOne’s IPO, China’s biotech power couple and Lilly’s eye drug deal. To get it in your inbox, subscribe here.
A deal between defecting Democrats and the Republicans may end the…
In this week’s edition of InnovationRx, we look at BillionToOne’s IPO, China’s biotech power couple and Lilly’s eye drug deal. To get it in your inbox, subscribe here.
A deal between defecting Democrats and the Republicans may end the…